148 related articles for article (PubMed ID: 31601299)
1. Identification of CDK6 and RHOU in Serum Exosome as Biomarkers for the Invasiveness of Non-functioning Pituitary Adenoma.
Yu S; Wang XS; Cao KC; Bao XJ; Yu J
Chin Med Sci J; 2019 Sep; 34(3):168-176. PubMed ID: 31601299
[TBL] [Abstract][Full Text] [Related]
2. Serum AGR2 as a useful biomarker for pituitary adenomas.
Tohti M; Li J; Tang C; Wen G; Abdujilil A; Yizim P; Ma C
Clin Neurol Neurosurg; 2017 Mar; 154():19-22. PubMed ID: 28092730
[TBL] [Abstract][Full Text] [Related]
3. Exosomal RNAs in the development and treatment of pituitary adenomas.
Chang M; Jiang S; Guo X; Gao J; Liu P; Bao X; Feng M; Wang R
Front Endocrinol (Lausanne); 2023; 14():1142494. PubMed ID: 36875488
[TBL] [Abstract][Full Text] [Related]
4. Elevated soluble epidermal growth factor receptor level in pituitary adenoma and carcinoma.
Kong YG; Ren ZY; Su CB; Wang RZ; Ma WB; Lian W
Chin Med Sci J; 2004 Sep; 19(3):199-202. PubMed ID: 15506648
[TBL] [Abstract][Full Text] [Related]
5. N-myc downstream-regulated gene 2 (NDRG2) promoter methylation and expression in pituitary adenoma.
Vaitkiene P; Valiulyte I; Glebauskiene B; Liutkeviciene R
Diagn Pathol; 2017 Apr; 12(1):33. PubMed ID: 28390436
[TBL] [Abstract][Full Text] [Related]
6. Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness.
Sánchez-Tejada L; Sánchez-Ortiga R; Moreno-Pérez O; Montañana CF; Niveiro M; Tritos NA; Alfonso AM
Endocrinol Nutr; 2013; 60(7):358-67. PubMed ID: 23416216
[TBL] [Abstract][Full Text] [Related]
7. Serum exosomes contain ECRG4 mRNA that suppresses tumor growth via inhibition of genes involved in inflammation, cell proliferation, and angiogenesis.
Mao L; Li X; Gong S; Yuan H; Jiang Y; Huang W; Sun X; Dang X
Cancer Gene Ther; 2018 Oct; 25(9-10):248-259. PubMed ID: 29983418
[TBL] [Abstract][Full Text] [Related]
8. Expression and clinical significance of doublecortin (DCX) in pituitary adenoma.
Liu X; Ma L; Wang Z; Ye J; Liu X; Jiang G; Wang H
Bull Cancer; 2019 Dec; 106(12):1080-1085. PubMed ID: 31376915
[TBL] [Abstract][Full Text] [Related]
9. Signal transducer and activator of transcription 3 (STAT3) promoter methylation and expression in pituitary adenoma.
Valiulyte I; Steponaitis G; Skiriute D; Tamasauskas A; Vaitkiene P
BMC Med Genet; 2017 Jul; 18(1):72. PubMed ID: 28709401
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs in Serum Exosomes as Potential Biomarkers in Clear-cell Renal Cell Carcinoma.
Zhang W; Ni M; Su Y; Wang H; Zhu S; Zhao A; Li G
Eur Urol Focus; 2018 Apr; 4(3):412-419. PubMed ID: 28753793
[TBL] [Abstract][Full Text] [Related]
11. EZH2 upregulation correlates with tumor invasiveness, proliferation, and angiogenesis in human pituitary adenomas.
Liu B; Pang B; Wang Q; Yang S; Gao T; Ding Q; Liu H; Yang Y; Fan H; Zhang R; Xin T; Xu G; Pang Q
Hum Pathol; 2017 Aug; 66():101-107. PubMed ID: 28666925
[TBL] [Abstract][Full Text] [Related]
12. Gene and protein expression in pituitary corticotroph adenomas: a systematic review of the literature.
Seltzer J; Ashton CE; Scotton TC; Pangal D; Carmichael JD; Zada G
Neurosurg Focus; 2015 Feb; 38(2):E17. PubMed ID: 25639319
[TBL] [Abstract][Full Text] [Related]
13. A novel risk model based on the correlation between the expression of basement membrane genes and immune infiltration to predict the invasiveness of pituitary adenomas.
Chen Z; Sun X; Kang Y; Zhang J; Jia F; Liu X; Zhu H
Front Endocrinol (Lausanne); 2022; 13():1079777. PubMed ID: 36686480
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of cyclin B1 plays potential roles in the invasiveness of pituitary adenomas.
Zhao P; Zhang P; Hu W; Wang H; Yu G; Wang Z; Li C; Bai J; Zhang Y
J Clin Neurosci; 2017 Sep; 43():267-273. PubMed ID: 28601573
[TBL] [Abstract][Full Text] [Related]
15. A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy.
McKiernan J; Donovan MJ; O'Neill V; Bentink S; Noerholm M; Belzer S; Skog J; Kattan MW; Partin A; Andriole G; Brown G; Wei JT; Thompson IM; Carroll P
JAMA Oncol; 2016 Jul; 2(7):882-9. PubMed ID: 27032035
[TBL] [Abstract][Full Text] [Related]
16. An Immuno-Biochip Selectively Captures Tumor-Derived Exosomes and Detects Exosomal RNAs for Cancer Diagnosis.
Yang Y; Kannisto E; Yu G; Reid ME; Patnaik SK; Wu Y
ACS Appl Mater Interfaces; 2018 Dec; 10(50):43375-43386. PubMed ID: 30451486
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase-9, a potential biological marker in invasive pituitary adenomas.
Gong J; Zhao Y; Abdel-Fattah R; Amos S; Xiao A; Lopes MB; Hussaini IM; Laws ER
Pituitary; 2008; 11(1):37-48. PubMed ID: 17768685
[TBL] [Abstract][Full Text] [Related]
18. Tumor-Derived Exosomal Long Noncoding RNAs as Promising Diagnostic Biomarkers for Prostate Cancer.
Wang YH; Ji J; Wang BC; Chen H; Yang ZH; Wang K; Luo CL; Zhang WW; Wang FB; Zhang XL
Cell Physiol Biochem; 2018; 46(2):532-545. PubMed ID: 29614511
[TBL] [Abstract][Full Text] [Related]
19. Exosome-transmitted long non-coding RNA PTENP1 suppresses bladder cancer progression.
Zheng R; Du M; Wang X; Xu W; Liang J; Wang W; Lv Q; Qin C; Chu H; Wang M; Yuan L; Qian J; Zhang Z
Mol Cancer; 2018 Oct; 17(1):143. PubMed ID: 30285771
[TBL] [Abstract][Full Text] [Related]
20. Transcriptomic analysis identifies a tumor subtype mRNA classifier for invasive non-functioning pituitary neuroendocrine tumor diagnostics.
Bao X; Wang G; Yu S; Sun J; He L; Zhao H; Ma Y; Wang F; Wang X; Wang R; Yu J
Theranostics; 2021; 11(1):132-146. PubMed ID: 33391466
[No Abstract] [Full Text] [Related]
[Next] [New Search]